Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
Status:
Completed
Trial end date:
2019-10-23
Target enrollment:
Participant gender:
Summary
This is a prospective cohort study focusing on HIV negative women. The investigators want to
learn how the contraceptive methods of depot medroxyprogesterone acetate (DMPA), etonogestrel
implant (Eng-Implant), levonorgestrel intrauterine device (Lng-IUD) and the ParaGard® T 380A
Intrauterine Copper Contraceptive impact the vaginal immune environment.
Phase:
Phase 4
Details
Lead Sponsor:
Lisa Haddad
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)